155 related articles for article (PubMed ID: 35955933)
21. Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma.
Cui H; Shan H; Miao MZ; Jiang Z; Meng Y; Chen R; Zhang L; Liu Y
Sci Rep; 2020 Mar; 10(1):4271. PubMed ID: 32144299
[TBL] [Abstract][Full Text] [Related]
22. SLC14A1 is a new biomarker in renal cancer.
Wan Z; Wang Y; Li C; Zheng D
Clin Transl Oncol; 2023 Aug; 25(8):2607-2623. PubMed ID: 37004669
[TBL] [Abstract][Full Text] [Related]
23. COLGALT1 is a potential biomarker for predicting prognosis and immune responses for kidney renal clear cell carcinoma and its mechanisms of ceRNA networks.
Liu S; Yu Y; Wang Y; Zhu B; Han B
Eur J Med Res; 2022 Jul; 27(1):122. PubMed ID: 35842702
[TBL] [Abstract][Full Text] [Related]
24. An effective seven-CpG-based signature to predict survival in renal clear cell carcinoma by integrating DNA methylation and gene expression.
Xu L; He J; Cai Q; Li M; Pu X; Guo Y
Life Sci; 2020 Feb; 243():117289. PubMed ID: 31926254
[TBL] [Abstract][Full Text] [Related]
25. HOXC11 functions as a novel oncogene in human colon adenocarcinoma and kidney renal clear cell carcinoma.
Cui Y; Zhang C; Wang Y; Ma S; Cao W; Guan F
Life Sci; 2020 Feb; 243():117230. PubMed ID: 31923422
[TBL] [Abstract][Full Text] [Related]
26. Overexpressing PTTG family genes predict poor prognosis in kidney renal clear cell carcinoma.
Gui Y; Liu X; Wang C; Yang P
World J Surg Oncol; 2021 Apr; 19(1):111. PubMed ID: 33845847
[TBL] [Abstract][Full Text] [Related]
27. Upregulated Transcription Factor PITX1 Predicts Poor Prognosis in Kidney Renal Clear Cell Carcinoma-Based Bioinformatic Analysis and Experimental Verification.
Zhang Y; Zhang Z; Zhang W; Hu H; Bao G
Dis Markers; 2021; 2021():7694239. PubMed ID: 34868397
[TBL] [Abstract][Full Text] [Related]
28. Identification of genes and pathways involved in kidney renal clear cell carcinoma.
Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M
BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354
[TBL] [Abstract][Full Text] [Related]
29. TACC3 is a prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune cell infiltration and T cell exhaustion.
Fan X; Liu B; Wang Z; He D
Aging (Albany NY); 2021 Mar; 13(6):8541-8562. PubMed ID: 33714201
[TBL] [Abstract][Full Text] [Related]
30. Identification of Pathologic Grading-Related Genes Associated with Kidney Renal Clear Cell Carcinoma.
Xiong W; Zhong J; Li Y; Li X; Wu L; Zhang L
J Immunol Res; 2022; 2022():2818777. PubMed ID: 35945960
[TBL] [Abstract][Full Text] [Related]
31. RIPK2 is an unfavorable prognosis marker and a potential therapeutic target in human kidney renal clear cell carcinoma.
Li D; Tang L; Liu B; Xu S; Jin M; Bo W
Aging (Albany NY); 2021 Mar; 13(7):10450-10467. PubMed ID: 33790054
[No Abstract] [Full Text] [Related]
32. Prognostic Value of
Yang CA; Huang HY; Yen JC; Chang JG
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29843367
[TBL] [Abstract][Full Text] [Related]
33. The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma.
Zhang W; Liu Z; Wang J; Geng B; Hou W; Zhao E; Li X
Front Immunol; 2022; 13():934387. PubMed ID: 35958561
[TBL] [Abstract][Full Text] [Related]
34. Identification of Survival Risk and Immune-Related Characteristics of Kidney Renal Clear Cell Carcinoma.
Wu X; Liang Y; Chen X; Long X; Xu W; Liu L; Wang B; Zou X
J Immunol Res; 2022; 2022():6149369. PubMed ID: 35832648
[TBL] [Abstract][Full Text] [Related]
35. BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis.
Ju Q; Li XM; Zhang H; Zhao YJ
Front Mol Biosci; 2020; 7():573619. PubMed ID: 33240929
[TBL] [Abstract][Full Text] [Related]
36. Semaphorin 7A in circulating regulatory T cells is increased in autosomal-dominant polycystic kidney disease and decreases with tolvaptan treatment.
Lee Y; Blount KL; Dai F; Thompson S; Scher JK; Bitterman S; Droher M; Herzog EL; Moeckel G; Karihaloo A; Dahl NK
Clin Exp Nephrol; 2018 Aug; 22(4):906-916. PubMed ID: 29453607
[TBL] [Abstract][Full Text] [Related]
37. NCF1/2/4 Are Prognostic Biomarkers Related to the Immune Infiltration of Kidney Renal Clear Cell Carcinoma.
Chen Y; He F; Wang R; Yao M; Li Y; Guo D; He S
Biomed Res Int; 2021; 2021():5954036. PubMed ID: 34708124
[TBL] [Abstract][Full Text] [Related]
38. A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis.
Hu F; Zeng W; Liu X
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739630
[TBL] [Abstract][Full Text] [Related]
39. LncRNA LOXL1-AS1/miR-28-5p/SEMA7A axis facilitates pancreatic cancer progression.
Liu Y; Guo C; Li F; Wu L
Cell Biochem Funct; 2020 Jan; 38(1):58-65. PubMed ID: 31732974
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M
Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]